Showing results (91-100 of 639) with videos related to
Sort By:
Pageof 64
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 22, 2020
Current Panorama and Challenges for Neoadjuvant Cancer ImmunotherapyJose Carlos Benitez, Jordi Remon, Benjamin BesseBulletin Du Cancer|December 6, 2006
[Neoadjuvant chemotherapy in non small cell lung cancer]Benjamin Besse, Stéphane Vignot, Thierry Le ChevalierBMC Medicine|March 14, 2017
Successes and failures: what did we learn from recent first-line treatment immunotherapy trials in non-small cell lung cancer?Jordi Remon, Benjamin Besse, Jean-Charles SoriaTranslational Lung Cancer Research|December 4, 2018
Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapyLizza E Hendriks, Etienne Rouleau, Benjamin BesseClinical and Translational Radiation Oncology|April 14, 2025
Brachytherapy: Perspectives for combined treatments with immunotherapyRaphaël Serre, Alexandra Gabro, Mickael Andraud, et al.Cardiovascular Research|January 31, 2019
Cardiac arrhythmia considerations of hormone cancer therapiesMary Barber, Lee S Nguyen, Johanna Wassermann, et al.Critical Reviews in Oncology/Hematology|May 1, 2009
Electrolyte disorders related to EGFR-targeting drugsHassane Izzedine, Rastilav Bahleda, David Khayat, et al.Investigational New Drugs|June 15, 2011
Phase I study of axitinib (AG-013736) in combination with gemcitabine in patients with advanced pancreatic cancerJean-Philippe Spano, Malcolm J Moore, Yazdi K Pithavala, et al.Critical Reviews in Oncology/Hematology|March 15, 2006
Cyclooxygenase-2 as a target for anticancer drug developmentJean-Baptiste Méric, Sylvie Rottey, Ken Olaussen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 13, 2017
Clinical and Translational Implications of RET Rearrangements in Non-Small Cell Lung CancerRoberto Ferrara, Nathalie Auger, Edouard Auclin, et al.Pageof 64